---
layout: default
title: Minoxidil
description: "Minoxidil çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚åˆæ­¥è­‰æ“šç­‰ç´š L4ï¼ŒåŒ…å« 3 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: ä¸­è­‰æ“šç­‰ç´š (L3-L4)
nav_order: 107
evidence_level: L4
indication_count: 3
---

# Minoxidil

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L4</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>3</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Minoxidilï¼šå¾é›„æ¿€ç´ æ€§ç¦¿é«®åˆ°é ­çš®å–®ç´”æ€§ç¨€æ¯›ç—‡

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Minoxidil å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Minoxidil åŸæœ¬ç”¨æ–¼æ²»ç™‚é›„æ¿€ç´ æ€§ç¦¿é«®å’Œé«˜è¡€å£“ã€‚
TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å°**é ­çš®å–®ç´”æ€§ç¨€æ¯›ç—‡ (hypotrichosis simplex of the scalp)** æœ‰æ•ˆï¼Œ
ç›®å‰æœ‰ **0 å€‹è‡¨åºŠè©¦é©—**å’Œ **3 ç¯‡æ–‡ç»**æ”¯æŒé€™å€‹æ–¹å‘ã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | æ²»ç™‚å¥³æ€§é›„æ¿€ç´ æ€§è½é«® |
| é æ¸¬æ–°é©æ‡‰ç—‡ | hypotrichosis simplex of the scalpã€congenital hypotrichosis miliaã€diffuse alopecia areata |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.99991655349731% |
| è­‰æ“šç­‰ç´š | L4 |
| å°ç£ä¸Šå¸‚ | âœ“ å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | 20 å¼µ |
| å»ºè­°æ±ºç­– | Research Question |

## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. hypotrichosis simplex of the scalp</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">100.00%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content" markdown="1">

### ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ

<p class="key-answer" data-question="é€™å€‹è—¥ç‰©çš„ä½œç”¨æ©Ÿè½‰æ˜¯ä»€éº¼ï¼Ÿ">
ç›®å‰ç¼ºä¹è©³ç´°çš„ä½œç”¨æ©Ÿè½‰è³‡æ–™ã€‚æ ¹æ“šå·²çŸ¥è³‡è¨Šï¼ŒMinoxidil æ˜¯ä¸€ç¨®å¤–ç”¨ç”Ÿé«®åŠ‘ï¼Œ
å…¶æˆåˆ†åœ¨é›„æ¿€ç´ æ€§ç¦¿é«®ä¸­çš„ç™‚æ•ˆå·²è¢«è­‰å¯¦ï¼Œæ©Ÿè½‰ä¸Šå¯èƒ½é©ç”¨æ–¼é ­çš®å–®ç´”æ€§ç¨€æ¯›ç—‡ã€‚
Minoxidil å¯èƒ½é€éä¿ƒé€²è¡€ç®¡æ“´å¼µå’Œå¢åŠ é ­çš®è¡€æµé‡ä¾†ä¿ƒé€²æ¯›é«®ç”Ÿé•·ã€‚
</p>

<div class="key-takeaway">
æ­¤é æ¸¬åŸºæ–¼è—¥ç‰©çš„ä½œç”¨æ©Ÿè½‰ï¼Œèˆ‡ç¾æœ‰è‡¨åºŠè­‰æ“šæ–¹å‘ä¸€è‡´ã€‚
</div>

### è‡¨åºŠè©¦é©—

ç›®å‰ç„¡ç›¸é—œè‡¨åºŠè©¦é©—ç™»è¨˜

### ç›¸é—œæ–‡ç»

| PMID | å¹´ä»½ | é¡å‹ | æœŸåˆŠ | ä¸»è¦ç™¼ç¾ |
|------|-----|------|------|---------|
| [35761391](https://pubmed.ncbi.nlm.nih.gov/35761391/) | 2022 | Case series | Dermatologic therapy | Treatment of hereditary hypotrichosis simplex of the scalp with oral minoxidil and growth factors. |
| [39902296](https://pubmed.ncbi.nlm.nih.gov/39902296/) | 2024 | Case series | Frontiers in genetics | Treatment of hypotrichosis simplex of the scalp with the combination of botanic extracts and minoxidil: a case report. |
| [36651821](https://pubmed.ncbi.nlm.nih.gov/36651821/) | 2023 | Case series | The Journal of dermatological treatment | Successful treatment of hereditary hypotrichosis simplex by platelet rich plasma injection with topical minoxidil 2. |

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. congenital hypotrichosis milia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">100.00%</span>
</summary>
<div class="indication-content" markdown="1">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š100.00%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. diffuse alopecia areata</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">100.00%</span>
</summary>
<div class="indication-content" markdown="1">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š100.00%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬027051è™Ÿ | è½å»ºå¥³æ€§å°ˆç”¨ç”Ÿé«®æ…•çµ² | æ°£åŒ–å™´éœ§åŠ‘ | æ²»ç™‚å¥³æ€§é›„æ¿€ç´ æ€§è½é«®ã€‚ |
| è¡›éƒ¨è—¥è£½å­—ç¬¬058412è™Ÿ | é«®å¯†è«¾ç”Ÿé«®æ¶²5% | å¤–ç”¨æ¶²åŠ‘ | é›„æ¿€ç´ æ€§ç¦¿é«®ã€‚ |
| è¡›éƒ¨è—¥è£½å­—ç¬¬059636è™Ÿ | ç¾å¾é«®æœ‰è¾¦é«®ç”Ÿé«®æ¶²2% | å¤–ç”¨æ¶²åŠ‘ | é›„æ¿€ç´ æ€§ç§ƒé«®ã€‚ |
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬026731è™Ÿ | æ•è«¾è¥¿è¿ª | ï¼ˆç²‰ï¼‰ | é™è¡€å£“åŠ‘ã€‚ |

## å®‰å…¨æ€§è€ƒé‡

- **è—¥ç‰©äº¤äº’ä½œç”¨**ï¼šMinoxidil èˆ‡å¤šç¨®è—¥ç‰©æœ‰ä¸­åº¦äº¤äº’ä½œç”¨ï¼ŒåŒ…æ‹¬ Hydrocortisoneã€Bupropionã€Triamcinoloneã€Morphineã€Dexamethasone ç­‰ã€‚

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**é…’ç²¾ (alcohol)** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šMany psychotherapeutic and CNS-active agents (e.g., anxiolytics, sedatives, hypnotics, antidepressants, antipsychotics, opioids, alcohol, muscle relaxants) exhibit hypotensive effects, especially duri...
- å»ºè­°ï¼šCaution and close monitoring for development of hypotension is advised during coadministration of these agents.  Some authorities recommend avoiding alcohol in patients receiving vasodilating antihype...


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**Kidney Failure, Chronic** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šPatients with renal failure or on dialysis may require a lower dosage of minoxidil as 21% of a dose is excreted unchanged in the urine...

**å¿ƒè‡Ÿè¡°ç«­** ğŸŸ¢ Minor
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚éœ€å¯†åˆ‡ç›£æ¸¬ã€‚

**Myocardial Ischemia** ğŸŸ¢ Minor
- éœ€å®šæœŸç›£æ¸¬ã€‚å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚

**Pheochromocytoma** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šResearch Question**

**ç†ç”±ï¼š**
ç›®å‰çš„æ–‡ç»æ”¯æŒæœ‰é™ï¼Œåƒ…æœ‰å°‘æ•¸æ¡ˆä¾‹å ±å‘Šï¼Œç¼ºä¹å¤§è¦æ¨¡è‡¨åºŠè©¦é©—çš„æ”¯æŒã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- é€²ä¸€æ­¥çš„è‡¨åºŠè©¦é©—ä»¥é©—è­‰ Minoxidil å°é ­çš®å–®ç´”æ€§ç¨€æ¯›ç—‡çš„ç™‚æ•ˆ
- è©³ç´°çš„è—¥ç‰©ä½œç”¨æ©Ÿè½‰è³‡æ–™ï¼ˆMOAï¼‰
- å®‰å…¨æ€§ç›£æ¸¬è¨ˆç•«ï¼Œå°¤å…¶æ˜¯é‡å°è—¥ç‰©äº¤äº’ä½œç”¨çš„å½±éŸ¿

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Silicon Dioxide]({{ "/drugs/silicon_dioxide/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Probenecid]({{ "/drugs/probenecid/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Prednisolone Acetate]({{ "/drugs/prednisolone_acetate/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Dl-Alpha-Tocopherol]({{ "/drugs/dl-alpha-tocopherol/" | relative_url }}) - è­‰æ“šç­‰ç´š L4
- [Salicylamide]({{ "/drugs/salicylamide/" | relative_url }}) - è­‰æ“šç­‰ç´š L4

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Minoxidilè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/minoxidil/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_minoxidil,
  title = {Minoxidilè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/minoxidil/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
